Profil
Paul Geudens is currently the Vice President-EMEA Sales & Marketing at Neuravi Ltd. He previously worked as the Director-Sales & Marketing at Stentys SA from 2011 to 2012, as a Principal at Johnson & Johnson, as the Executive Vice President-Operations at Caliber Therapeutics, Inc., and as a Principal at Surpass Medical Ltd.
Aktiva positioner av Paul Geudens
| Företag | Position | Start |
|---|---|---|
Neuravi Ltd.
Neuravi Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices | Försäljning & Marknadsföring | - |
Tidigare kända positioner av Paul Geudens
| Företag | Position | Slut |
|---|---|---|
Surpass Medical Ltd.
Surpass Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Provides medical devices | Företagsledare/Principal | - |
Caliber Therapeutics, Inc.
Caliber Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products for atherosclerotic diseases | Verksamhetschef | - |
| JOHNSON & JOHNSON | Företagsledare/Principal | - |
| STENTYS | Försäljning & Marknadsföring | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Stentys SA
Stentys SA Medical SpecialtiesHealth Technology Engages in development and production of coronary stents | Health Technology |
Neuravi Ltd.
Neuravi Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Caliber Therapeutics, Inc.
Caliber Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products for atherosclerotic diseases | Health Technology |
Surpass Medical Ltd.
Surpass Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Provides medical devices | Electronic Technology |
















